FDA Inspection
Chongqing Carelife Pharmaceutical Co., Ltd.Chongqing Carelife Pharmaceutical Co., Ltd. – FDA Inspection, Nov 30, 2017
Record Details
This FDA Inspection record concerns Chongqing Carelife Pharmaceutical Co., Ltd., with an inspection on November 30, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · a3d54cae-08f1-4200-85a5-c3844dbf7dde
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1035442
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Chongqing Carelife Pharmaceutical Co., Ltd.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| March 28, 2025 | Not classified | Office of Inspections and Investigations | |
| July 19, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 19, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 18, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 30, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Chongqing Carelife Pharmaceutical Co., Ltd.
- FDA Inspection 1268964 - 2025-03-28
- FDA Inspection 1098996 - 2019-07-19
- FDA Inspection 970028 - 2016-05-19
- FDA Inspection 851858 - 2013-10-18
- FDA Inspection 684797 - 2010-07-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.